Weill Cornell Medicine – Qatar (WCM-Q) is at the forefront of medical education, clinical care, and biomedical research in the Middle East.

Established in 2001 as a partnership between Cornell University in the US and QF, WCM-Q is part of Cornell University and was the first US university to offer its MD degree overseas. From their very first year, medical students gain clinical experience with the country’s finest healthcare providers, and go on to residencies in some of the best teaching hospitals in the world.

WCM-Q’s Division of Continuing Professional Development is accredited to provide continuing medical education for physicians and in doing so disseminates information about clinical best practice, augmenting local healthcare delivery. In line with their commitment to focus on diseases prevalent in Qatar, WCM-Q established a world-class biomedical research program, the first of its kind in the Middle East, that will help inform more efficient healthcare delivery by ushering in the era of precision medicine. The biomedical research program also provides robust training programs, helping to build local research capacity and contributing to Qatar’s knowledge economy.

WCM-Q’s affiliation with Cornell University and Weill Cornell Medicine in New York, as well as with the Ministry of Public Health, Hamad Medical Corporation, Sidra Medicine, Aspetar, the Feto Maternal Center and the Primary Health Care Corporation, has created powerful partnerships that are dedicated to delivering excellence in education, patient care and biomedical research. qatar–weill.cornell.edu